Skip to content
Recall Observatory FDA recall evidence

Drug product

Nystatin Oral Suspension, USP 500,000 Units/5 mL, a). 50 unit dose cups of 5 mL per case (NDC No. 66689-037-50), b). 100 unit dose cups of 5 mL per case (NDC 66689-037-99), Rx only, Manufactured by VistaPharm, Largo, FL 33771.

D-0461-2017

January 18, 2017

Class II

Product summary

Firm
VistaPharm, Inc.
Event
Event 75650
Status
Terminated
Classification
Class II
Quantity
55,191 unit dose cups
Official record key
drug-enforcement:D-0461-2017

Official wording

Reason: CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Code information: a). Lot No. 428900, 425600 (Exp. 05/17); 421200 (Exp. 04/17), 413600 (Exp. 02/17), 411500 (Exp. 01/17), 417200 (Exp. 03/17) b). Lot No. 429300 (Exp. 06/17) ,426500 (Exp. 05/17), 420600 (Exp. 03/17), 417000 (Exp.03/17), 412900 (Exp. 01/17), 409900 (Exp. 01/17)

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations
  • Microbial contamination

    reason.microbial_contamination · v1.0.0

    contaminated with Burkholderia cepacia